Factor V Leiden mutation in patients with polyarthralgia – case reports and review of literature
Vol. 32 No. 3 (2024), Case reports
Vol. 32 No. 3 (2024)

Factor V Leiden mutation in patients with polyarthralgia – case reports and review of literature

Case reports
https://doi.org/10.35465/32.3.2024.pp78-85
Published December 29, 2024
Dobromir Tanev
UMBAL SofiaMed
R. Robeva
S. Andonova
A. Savov
PDF BG (Български)
PDF ENG

Keywords

arthralgia, factor V Leiden, corticosteroid treatment, thrombosis

How to Cite

Tanev, D., Robeva, R., Andonova, S., & Savov, A. (2024). Factor V Leiden mutation in patients with polyarthralgia – case reports and review of literature. Rheumatology (Bulgaria), 32(3), 78-85. https://doi.org/10.35465/32.3.2024.pp78-85
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Patients with rheumatological diseases might be at increased risk of venous thromboembolism (VTE) because of inflammation, autoimmune disturbances, prolonged immobilization, and corticosteroid (CS) use. Therefore, more efforts are needed to identify additional prothrombotic factors and provide preventive strategies.

Herein, we presented two cases of young men with polyarthralgia who have undergone unprovoked VTE. The first patient underwent VTE after several intra-articular CS applications, while the other had no concomitant risk factors. The hereditary thrombophilia testing revealed a heterozygous Factor V Leiden (FVL) state in the first patient and homozygous FVL carrier status in the second patient. 

Both cases suggest a possible benefit of thrombophilia testing in men under the age of 50 years with polyarthralgia, unprovoked VTE, and impending CS therapy. Estimating the complex thrombotic risk in rheumatological patients before CS use is crucial for preventing thromboses. 

https://doi.org/10.35465/32.3.2024.pp78-85
PDF BG (Български)
PDF ENG

References

  1. Misra DP, Ahmed S, Goyal M et al. Thromboembolism in the Inflammatory Rheumatic Diseases. Rheum Dis Clin North Am. 2023 Feb;49(1):97-127.
  2. Arachchillage DJ, Mackillop L, Chandratheva A et al. Thrombophilia testing: A British Society for Haematology guideline. Br J Haematol. 2022;198(3):443-458.
  3. Brouwer JL, Bijl M, Veeger NJ et al. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004;104(1):143-148.
  4. Kujovich JL. Factor V. Leiden thrombophilia. Genet Med. 2011;13(1):1-16.
  5. Favaloro EJ, McDonald D. Futility of testing for factor V Leiden. Blood Transfus. 2012;10(3):260-263.
  6. Ashraf N, Visweshwar N, Jaglal M et al. Evolving paradigm in thrombophilia screening. Blood Coagul Fibrinolysis. 2019;30(5):249-252.
  7. Samanta J, Kendall J, Samanta A. Polyarthralgia. BMJ. 2003 Apr 19;326(7394):859.
  8. Ley R, Conaghan PG. Early diagnosis crucial in polyarthralgia. Practitioner. 2007;251(1701):17-8, 21-22.
  9. Zale EL, Maisto SA, Ditre JW. Interrelations between pain and alcohol: An integrative review. Clin Psychol Rev. 2015; 37:57-71.
  10. Thompson T, Oram C, Correll CU. Tsermentseli S, Stubbs B. Analgesic Effects of Alcohol: A Systematic Review and Meta-Analysis of Controlled Experimental Studies in Healthy Participants. J Pain. 2017;18(5):499-510.
  11. Robins MT, Heinricher MM, Ryabinin AE. From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception. Alcohol Alcohol. 2019;54(6):625-638.
  12. Cucinello-Ragland JA, Alrashed NH, Lee S et al. Sex-specific
  13. biobehavioral regulation of persistent inflammatory pain by alcohol. Alcohol Clin Exp Res (Hoboken). 2023;47(7):1283-1296.
  14. Woodrow KM, Eltherington LG. Feeling no pain: alcohol as an analgesic. Pain. 1988;32(2):159-163.
  15. Witkiewitz K, Vowles KE, McCallion E et al. Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial. Addiction. 2015;110(8):1262-1271.
  16. Cucinello-Ragland JA, Edwards S. Neurobiological aspects of pain in the context of alcohol use disorder. Int Rev Neurobiol. 2021;157:1-29.
  17. Huerta C, Johansson S, Wallander MA, García Rodríguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167(9):935-943.
  18. Johannesdottir SA, Horváth-Puhó E, Dekkers OM et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med. 2013;173(9):743-752.
  19. Habib GS. Systemic effects of intra-articular corticosteroids. Clin Rheumatol. 2009;28(7):749-756.
  20. Stout A, Friedly J, Standaert CJ. Systemic Absorption and Side Effects of Locally Injected Glucocorticoids. PM R. 2019;11(4):409-419.
  21. Modarelli RE, Stephen MD. Depot triamcinolone injection contributing to adrenal suppression and Cushing syndrome: case report and literature review. AACE Clin Case Rep. 2019;5(1):e1-e3.
  22. Alidoost M, Conte GA, Agarwal K et al. Iatrogenic Cushing›s
  23. Syndrome Following Intra-Articular Triamcinolone Injection
  24. in an HIV-Infected Patient on Cobicistat Presenting as a Pulmonary Embolism: Case Report and Literature Review. Int Med Case Rep J. 2020;13:229-235.
  25. Stevens SM, Woller SC, Bauer KA et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016;41(1):154-164.
  26. Mazzolai L, Duchosal MA. Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening. Eur J Vasc Endovasc Surg. 2007;34(4):483-488.
  27. Middeldorp S. Is thrombophilia testing useful? Hematology Am Soc Hematol Educ Program. 2011;2011:150-155.
  28. Colucci G, Tsakiris DA. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis. 2020;49(4):618-629.
  29. Pernod G, Biron-Andreani C, Morange PE et al. French group on haemostasis and thrombosis; French Society of vascular medicine. Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc. 2009;34(3):156-203.
  30. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85(6):1504-1508.
  31. Arsov T, Miladinova D, Spiroski M. Factor V. Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Croat Med J. 2006;47(3):433-439.
  32. Ivanov P, Komsa-Penkova R, Kovacheva K et al. Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences. Lung. 2008;186(1):27-36.
  33. Bashal F. Thrombosis in Rheumatological Diseases. 2021 Jan 6. In: Almoallim H, Cheikh M, editors. Skills in Rheumatology [Internet]. Singapore: Springer; 2021. Chapter 12.
  34. Riancho-Zarrabeitia L, Lopez-Marin L, Cacho PM, et al. Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis. Lupus. 2022;31(7):808-819.
  35. Chighizola CB, Ubiali T, Meroni PL. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches. J Immunol Res. 2015; 2015:951424.
  36. Orsi FA, Lijfering WM, Geersing GJ et al. Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study. Br J Haematol. 2021;193(6):1194-1202.
  37. Wagner J, Langlois F, Lim DST et al. Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing’s Syndrome: A Systematic Meta-Analysis. Front Endocrinol (Lausanne). 2019;9:805.
  38. Koraćević G, Stojanović M, Petrović S et al. Cushing’s syndrome, a risk factor for venous thromboembolism is a candidate for guidelines. Acta Endocrinol (Buchar). 2020;16(2):123-128.
  39. Majoor CJ, Sneeboer MM, de Kievit A et al. The influence of corticosteroids on hemostasis in healthy subjects. J Thromb Haemost. 2016;14(4):716-723.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.

Most read articles by the same author(s)